Autologous Stem Cell Transplantation: An Effective Salvage Therapy in Multiple Myeloma
Open Access
- 1 March 2013
- journal article
- research article
- Published by Elsevier BV in Transplantation and Cellular Therapy
- Vol. 19 (3), 445-449
- https://doi.org/10.1016/j.bbmt.2012.11.013
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Superiority of the Triple Combination of Bortezomib-Thalidomide-Dexamethasone Over the Dual Combination of Thalidomide-Dexamethasone in Patients With Multiple Myeloma Progressing or Relapsing After Autologous Transplantation: The MMVAR/IFM 2005-04 Randomized Phase III Trial From the Chronic Leukemia Working Party of the European Group for Blood and Marrow TransplantationJournal of Clinical Oncology, 2012
- Durable remission with salvage second autotransplants in patients with multiple myelomaCancer, 2011
- Stem cell transplant: an effective salvage therapy for multiple myelomaLeukemia & Lymphoma, 2011
- Current Trends in Autologous Stem-Cell Transplantation for Myeloma in the Era of Novel TherapiesJournal of Clinical Oncology, 2011
- Second auto-SCT is safe and effective salvage therapy for relapsed multiple myelomaBone Marrow Transplantation, 2008
- Lenalidomide plus Dexamethasone for Relapsed Multiple Myeloma in North AmericaNew England Journal of Medicine, 2007
- Lenalidomide plus Dexamethasone for Relapsed or Refractory Multiple MyelomaNew England Journal of Medicine, 2007
- Extended follow-up of a phase 3 trial in relapsed multiple myeloma: final time-to-event results of the APEX trialBlood, 2007
- High-Dose Chemotherapy with Hematopoietic Stem-Cell Rescue for Multiple MyelomaNew England Journal of Medicine, 2003
- A Prospective, Randomized Trial of Autologous Bone Marrow Transplantation and Chemotherapy in Multiple MyelomaNew England Journal of Medicine, 1996